These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 28497642)

  • 1. Estimating lifetime medical costs from censored claims data.
    Hwang JS; Hu TH; Lee LJ; Wang JD
    Health Econ; 2017 Dec; 26(12):e332-e344. PubMed ID: 28497642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of life expectancy, loss-of-life expectancy, and lifetime healthcare expenditures for schizophrenia in Taiwan.
    Lêng CH; Chou MH; Lin SH; Yang YK; Wang JD
    Schizophr Res; 2016 Mar; 171(1-3):97-102. PubMed ID: 26811230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lifetime Risks, Life Expectancy, and Health Care Expenditures for Rheumatoid Arthritis: A Nationwide Cohort Followed Up From 2003 to 2016.
    Chiu YM; Lu YP; Lan JL; Chen DY; Wang JD
    Arthritis Rheumatol; 2021 May; 73(5):750-758. PubMed ID: 33295139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Life Expectancy and Lifetime Health Care Expenditures for Type 1 Diabetes: A Nationwide Longitudinal Cohort of Incident Cases Followed for 14 Years.
    Ou HT; Yang CY; Wang JD; Hwang JS; Wu JS
    Value Health; 2016 Dec; 19(8):976-984. PubMed ID: 27987648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QALYs and medical costs saved from prevention of a cancer: Analysis of nation-wide real-world data of Taiwan with lifetime horizon.
    Lai WW; Chung CH; Lin CN; Yang SC; Hwang JS; Wang JD
    J Formos Med Assoc; 2021 Dec; 120(12):2089-2099. PubMed ID: 34020855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating Life Expectancy and Lifetime Healthcare Costs for Alzheimer's Disease in Taiwan: Does the Age of Disease Onset Matter?
    Yeh TS; Wang JD; Ku LE
    J Alzheimers Dis; 2020; 73(1):307-315. PubMed ID: 31771049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lifetime medical expenditure and life expectancy lost attributable to smoking through major smoking related diseases in Taiwan.
    Chung CW; Wang JD; Yu CF; Yang MC
    Tob Control; 2007 Dec; 16(6):394-9. PubMed ID: 18048616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lifetime risks and health impacts of hemorrhagic and ischemic stroke in South Korea.
    Cheon S; Lee H; Won J; Jang BH; Wang JD
    Sci Rep; 2020 Sep; 10(1):14544. PubMed ID: 32884001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of work-related cancers in Taiwan-Estimation with QALY (quality-adjusted life year) and healthcare costs.
    Lee LJ; Lin CK; Hung MC; Wang JD
    Prev Med Rep; 2016 Dec; 4():87-93. PubMed ID: 27413666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lifetime cost of diabetes and its implications for diabetes prevention.
    Zhuo X; Zhang P; Barker L; Albright A; Thompson TJ; Gregg E
    Diabetes Care; 2014 Sep; 37(9):2557-64. PubMed ID: 25147254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lifetime risks, expected years of life lost, and cost-per-life year of esophageal cancer in Taiwan.
    Lai WW; Lin CN; Chang CC; Wang JD
    Sci Rep; 2020 Feb; 10(1):3722. PubMed ID: 32111930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of benefit of prevention of occupational cancer for comparative risk assessment: methods and examples.
    Lee LJ; Chang YY; Liou SH; Wang JD
    Occup Environ Med; 2012 Aug; 69(8):582-6. PubMed ID: 22576592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality-adjusted life expectancy (QALE) and loss of QALE for patients with ischemic stroke and intracerebral hemorrhage: a 13-year follow-up.
    Lee HY; Hwang JS; Jeng JS; Wang JD
    Stroke; 2010 Apr; 41(4):739-44. PubMed ID: 20150543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of Life-Year Loss and Lifetime Costs for Different Stages of Colon Adenocarcinoma in Taiwan.
    Chen PC; Lee JC; Wang JD
    PLoS One; 2015; 10(7):e0133755. PubMed ID: 26207912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of life expectancy and the expected years of life lost in patients with major cancers: extrapolation of survival curves under high-censored rates.
    Chu PC; Wang JD; Hwang JS; Chang YY
    Value Health; 2008 Dec; 11(7):1102-9. PubMed ID: 18489497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute treatment costs of intracerebral hemorrhage and ischemic stroke in Argentina.
    Christensen MC; Previgliano I; Capparelli FJ; Lerman D; Lee WC; Wainsztein NA
    Acta Neurol Scand; 2009 Apr; 119(4):246-53. PubMed ID: 18771525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct costs of patients with stroke can be continuously monitored on a national level: performance, effectiveness, and Costs of Treatment episodes in Stroke (PERFECT Stroke) Database in Finland.
    Meretoja A; Kaste M; Roine RO; Juntunen M; Linna M; Hillbom M; Marttila R; Erilä T; Rissanen A; Sivenius J; Häkkinen U
    Stroke; 2011 Jul; 42(7):2007-12. PubMed ID: 21527757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-year follow-up healthcare costs of patients hospitalized for transient ischemic attack or ischemic stroke and discharged with aspirin plus extended-release dipyridamole or clopidogrel.
    Burton TM; Lacey M; Liu F; Yu Y; Monsalvo ML; Lang K; Sander S
    J Med Econ; 2012; 15(6):1217-25. PubMed ID: 22857539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic evaluation of atorvastatin for prevention of recurrent stroke based on the SPARCL trial.
    Kongnakorn T; Ward A; Roberts CS; O'Brien JA; Proskorovsky I; Caro JJ
    Value Health; 2009 Sep; 12(6):880-7. PubMed ID: 19490555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of medical spending in the United States, 1960-2000.
    Cutler DM; Rosen AB; Vijan S
    N Engl J Med; 2006 Aug; 355(9):920-7. PubMed ID: 16943404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.